Hudson Bay Capital Management
CBIO

Hudson Bay Capital Management’s Crescent Biopharma CBIO Stock Holding History

Hudson Bay Capital Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.63M Buy
+88,867
New +$1.02M 0.01% 802
2019
Q3 		– Sell
-3,000
Closed -$3.58M – 450
2019
Q2 		$3.58M Buy
3,000
+500
+20% +$598K 0.1% 218
2019
Q1 		$3.12M Sell
2,500
-1,000
-29% -$1.14M 0.09% 379
2018
Q4 		$3.31M Buy
3,500
+1,800
+106% +$2.17M 0.1% 394
2018
Q3 		$2.45M Buy
1,700
+500
+42% +$756K 0.06% 418
2018
Q2 		$1.94M Buy
1,200
+200
+20% +$344K 0.06% 515
2018
Q1 		$1.62M Sell
1,000
-400
-29% -$832K 0.06% 488
2017
Q4 		$2.35M Buy
1,400
+150
+12% +$198K 0.08% 289
2017
Q3 		$1.75M Buy
1,250
+448
+56% +$526K 0.07% 258
2017
Q2 		$894K Buy
+802
New +$663K 0.04% 425

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM